Company / Cash & Equivalents
QHSLab, Inc. Cash & Equivalents History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$636.2K
FY2025
5-year range
$51.6K / $636.2K
FY2021-FY2025
Trend
+304.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents changed +305% YoY in FY2025, a notable deviation from the 5-year average annual change of +121%.
Based on SEC 10-K filings.
$636,157 in FY2025 with a 5-year CAGR of +46.5%.
Improved from $51,582 to $636,157 over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +52.7%
- 5-Year CAGR
- +46.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +46.5%, indicating consistent growth.
- In FY2025, cash & equivalents increased 304.8% year-over-year.
- Lowest cash & equivalents in the period was in FY2023.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $636.2K | +304.8% |
| FY2024 | $157.2K | +204.7% |
| FY2023 | $51.6K | -71.1% |
| FY2022 | $178.7K | -37.7% |
| FY2021 | $286.9K | +204.1% |
| FY2020 | $94.3K | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2013 | - | - |
| FY2012 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026